Product Overview

Rabeprazole Sodium IP 20 mg [Enteric Coated] + Domperidone 30 mg [Sustained Release] is a combination pharmaceutical formulation developed for the management of acid-related gastrointestinal conditions accompanied by symptoms such as nausea, vomiting, and impaired gastric motility. The formulation combines effective gastric acid suppression with gastrointestinal motility support to provide comprehensive symptomatic relief under medical supervision.

Rabeprazole Sodium belongs to the proton pump inhibitor (PPI) class and works by reducing gastric acid production in the stomach. It inhibits the proton pumps responsible for the final stage of gastric acid secretion, helping relieve acidity, heartburn, and acid reflux while supporting the healing of acid-related irritation in the gastrointestinal tract.

Domperidone is a gastrointestinal prokinetic and antiemetic agent that helps improve gastric motility and supports the movement of food through the digestive tract. It also helps manage nausea and vomiting associated with certain gastrointestinal conditions.

The combination provides a dual-action approach by addressing both excessive gastric acid production and gastrointestinal motility-related symptoms. The enteric-coated form of Rabeprazole helps protect the active ingredient from degradation in the acidic stomach environment, while the sustained-release form of Domperidone is designed to provide prolonged therapeutic support.

Key Features

• Dual-action gastrointestinal formulation
• Helps reduce excessive gastric acid production
• Supports relief from acidity, heartburn, and acid reflux
• Helps manage nausea and vomiting
• Supports healthy gastrointestinal motility
• Enteric-coated and sustained-release formulation
• Reliable and consistent therapeutic performance

Uses

• Gastroesophageal reflux disease (GERD) management
• Acidity and heartburn relief
• Acid reflux symptom management
• Nausea and vomiting associated with gastrointestinal conditions
• Digestive discomfort and impaired gastric motility support

How It Works

Rabeprazole Sodium reduces gastric acid secretion by inhibiting proton pumps in the stomach. Domperidone supports gastrointestinal motility and helps control nausea and vomiting. Together, they provide comprehensive support for acid-related and motility-associated gastrointestinal symptoms.

Possible Side Effects

Common side effects may include:

• Headache
• Nausea
• Abdominal discomfort
• Diarrhea or constipation
• Dry mouth
• Dizziness
• Bloating

Patients should seek medical attention if severe allergic reactions, persistent abdominal pain, unusual heart rhythm, or other serious symptoms occur.

Precautions

• Use only under medical supervision
• Inform your doctor about liver, kidney, or heart conditions
• Inform your healthcare provider about all medications being taken
• Avoid prolonged self-medication
• Pregnant or breastfeeding women should consult a healthcare professional before use

Storage Instructions

Store in a cool, dry place away from direct sunlight, heat, and moisture. Keep out of reach of children and use before the expiry date mentioned on the packaging.

Quality Assurance

Manufactured under stringent pharmaceutical quality control procedures, the formulation undergoes comprehensive testing to ensure purity, safety, consistency, and dependable therapeutic performance. Each batch is carefully evaluated to maintain consistent pharmaceutical quality and reliable healthcare standards.